Found: 11
Select item for more details and to access through your institution.
Tetrathiomolybdate mediates cisplatin-induced p38 signaling and EGFR degradation and enhances response to cisplatin therapy in gynecologic cancers.
- Published in:
- Scientific Reports, 2015, p. 15911, doi. 10.1038/srep15911
- By:
- Publication type:
- Article
Adaptive transcriptomic and immune infiltrate responses in the tumor immune microenvironment following neoadjuvant chemotherapy in high grade serous ovarian cancer reveal novel prognostic associations and activation of pro-tumorigenic pathways.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.965331
- By:
- Publication type:
- Article
Immune Modeling Analysis Reveals Immunologic Signatures Associated With Improved Outcomes in High Grade Serous Ovarian Cancer.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.622182
- By:
- Publication type:
- Article
Multi-omic profiling reveals discrepant immunogenic properties and a unique tumor microenvironment among melanoma brain metastases.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00471-z
- By:
- Publication type:
- Article
Intratumoral expression analysis reveals that OX40 and TIM-3 are prominently expressed and have variable associations with clinical outcomes in high grade serous ovarian cancer.
- Published in:
- Oncology Letters, 2022, v. 23, n. 6, p. N.PAG, doi. 10.3892/ol.2022.13308
- By:
- Publication type:
- Article
Targeting TBP-associated factors in ovarian cancer.
- Published in:
- Frontiers in Oncology, 2014, v. 4, p. 1, doi. 10.3389/fonc.2014.00045
- By:
- Publication type:
- Article
The biomarker HE4 (WFDC2) promotes a pro-angiogenic and immunosuppressive tumor microenvironment via regulation of STAT3 target genes.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-65353-x
- By:
- Publication type:
- Article
A bioinformatic analysis of WFDC2 (HE4) expression in high grade serous ovarian cancer reveals tumor-specific changes in metabolic and extracellular matrix gene expression.
- Published in:
- 2022
- By:
- Publication type:
- journal article
The Perfect Combination: Enhancing Patient Response to PD-1-Based Therapies in Epithelial Ovarian Cancer.
- Published in:
- Cancers, 2020, v. 12, n. 8, p. 2150, doi. 10.3390/cancers12082150
- By:
- Publication type:
- Article
Beyond the Biomarker: Understanding the Diverse Roles of Human Epididymis Protein 4 in the Pathogenesis of Epithelial Ovarian Cancer.
- Published in:
- Frontiers in Oncology, 2018, p. 1, doi. 10.3389/fonc.2018.00124
- By:
- Publication type:
- Article
Human Epididymis Protein 4 Promotes Events Associated with Metastatic Ovarian Cancer via Regulation of the Extracelluar Matrix.
- Published in:
- Frontiers in Oncology, 2018, p. 1, doi. 10.3389/fonc.2017.00332
- By:
- Publication type:
- Article